Latest news, reports, and more from the RedChip Nation.
 
Discovering Tomorrow's Blue Chips Today
April 7, 2021     Contact    
Featured This Week
 
Killi Launches Transformational Product That Reveals How Consumers’ Personal Data is Being Sold While Providing Consumers the Opportunity to Monetize Their Data
 

 

Unveils Data on 320 Million Americans, becoming the first Company to allow Consumers to View & Reclaim Control of Their Online Data, Addressing a $247 Billion Industry


Killi Ltd. (TSXV: MYID, OTCQB: MYIDD) (“Killi”) announced the launch of Killi Unveil, an online platform that allows 320 million consumers in the US to securely access their own online data profiles, profiles that until today have remained inaccessible to them. The platform authenticates consumers’ personal identity, allowing them to retrieve and see how corporations are using their personal data. Once retrieved, consumers can view over 200 attributes collected and sold without their express permission.


“Every single person on the planet over the age of 16 has a digital profile that until now has been inaccessible to them. Corporations are generating approximately $6,000 a year on each consumer by selling their data,” said Killi founder and CEO Neil Sweeney.


Killi’s new platform also provides consumers the ability to edit their data - both a gap in the current data market and a requirement in California’s new privacy regulation Proposition 24. As data usage and acquisition has never typically included the consumer, there has never been a way for data to be updated. The result has been stale, outdated files being traded by parties, lowering the data’s efficacy and integrity. In working with Killi, companies can acquire user consent and more accurate files due to the profiles’ editability while redistributing dollars back to consumers.


Killi believes that all data is a manifestation of consumer identity and that redistributing control and compensation to the consumer is a critical component of participation in an evolving market. Kili Unveil is the latest iteration in Killi’s continued efforts for increasing consumer inclusion and compensation.


Sweeney continued, “There has been no destination for consumers to view, edit, opt-out, or be compensated for the use of this data, until now. At Killi, we believe consumers should have control of how their information is being collected and used. The notion that companies can continue to collect and sell consumers’ data without their involvement is an antiquated model that we are exposing and changing. Our innovative platform accelerates our mission of becoming the leading global brand associated with transparency and privacy for consumers.”


Learn more at MYIDDinfo.com.

 
 >
Latest News
 
Amesite (NASDAQ: AMST) Announces Launch of Warrior TechSource, a Best-in-Class A.I. Driven Online Learning Platform for Professionals in the Automotive Engineering Industry
 >
Can-Fite BioPharma (NYSE American: CANF) Announces Summary of Existing Out-licensing Deals with Potential Milestone Payments of up to approximately $130 million
 >
1847 Goedeker (NYSE American: GOED) Announces Fiscal Year 2020 Results with Written Orders Up 99% to $123.2M on 57% YoY Increase in Site Sessions
 
 
Lantern Pharma (NASDAQ: LTRN) Expands Portfolio of Cancer Opportunities for LP-184 with ATRT Pediatric Brain Tumor Collaboration with Johns Hopkins
 
 
LMP Automotive (NASDAQ: LMPX) Announces a Definitive Acquisition Agreement for 85% of two Chrysler Jeep Dodge Ram Dealerships in New York Generating Approximately $270 Million in Annualized Revenue
 
 
Kiromic BioPharma (NASDAQ: KRBP) Reports Fiscal Year 2020 Financial Results and Continued Corporate Progress
 
 
DSS (NYSE American: DSS) Releases Full Year 2020 Financial Results: Income from Continuing Operations Increased $5.7 Million in 2020
 
 
Tiziana Life Sciences (NASDAQ: TLSA) ) Announces the FDA Has Allowed Treatment for a Secondary Progressive Multiple Sclerosis (SPMS) Patient for the Nasal Administration of Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody, Under an Individual Patient Expanded Access Program
 
 
Aridis Pharmaceuticals (NASDAQ: ARDS) Announces 2020 Fourth Quarter and Year-End Financial Results and Business Update
 
 
Aptorum Group (NASDAQ: APM) Announces Dosing First Human Subject in a Phase I Clinical Trial of ALS-4, a First-in-Class Small Molecule Drug Designed to Treat Infections caused by Staphylococcus Aureus including Methicillin-resistant Staphylococcus aureus (MRSA]
 
 
SPI Energy (NASDAQ: SPI) Announces Full Repayment of Convertible Promissory Note
 
 
Milestone Scientific (NYSE American: MLSS) Provides 2020 Year-End Business Update; Reports a 78% Sequential Increase in Revenue for Q4 2020 Versus Q3 2020
 
 
1847 Holdings (OTCQB: EFSH) Completes Acquisition of Wolo, a Leading Manufacturer and Distributor of Vehicle Horns and Warning Lights
 
 
American Resources (NASDAQ: AREC) Provides Update on Perry County Resources Complex and American Carbon Division
 
 
BTCS (OTCQB: BTCS) Welcomes New Independent Director to Strengthen Corporate Governance in Preparation for Planned Uplist to Senior Exchange
 
 
Recruiter.com (OTCQB: RCRT) Recruiter Index(R) to be Featured on CNBC for 11th Consecutive Month
 
 
Digital Ally (NASDAQ: DGLY) Inks New Multi-Year Contract to Outfit Officers and Vehicles with Body-Worn and In-Car Camera Systems
 
 
Bragg Gaming (OTC: BRGGF) Announces Shareholder Meeting and Intent to List on the Nasdaq Stock Market
 
 
CBD of Denver (OTC: CBDD) Becomes One of the First CBD Companies to Accept Bitcoin and Other Crypto Currencies
 
 
 
Upcoming Zoom Webinar
 
 
 
 

Join Zoom Meeting: zoom.us/j/93228937962
One tap mobile
US: +13017158592,,93228937962#,,,,*250766# or
+13126266799,,93228937962#,,,,*250766#
Or Telephone:
Dial(for higher quality, dial a number based on your current location):
+1 646 558 8656 US (New York)
+1 301 715 8592 US (Washington D.C)
+1 312 626 6799 US (Chicago)
+1 669 900 9128 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)

Webinar ID: 932 2893 7962
Passcode: 250766
International numbers available:
zoom.us/u/abfNuNm6Jx


 
 
 

Join Zoom Meeting: zoom.us/j/98283964586
One tap mobile
US: +13126266799,,98283964586# or
+16465588656,,98283964586#
Or Telephone:
Dial(for higher quality, dial a number based on your current location):
+1 646 558 8656 US (New York)
+1 301 715 8592 US (Washington D.C)
+1 312 626 6799 US (Chicago)
+1 669 900 9128 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)

Webinar ID: 982 8396 4586
International numbers available:
zoom.us/u/aFiE3MAX6


 
 
 
 
 
 
 
 
 
 
 
Quote of the Week
 
"Do your homework, understand companies you invest in forwards and backwards."
- Charles Diker, Diker Management-Microcap Superstar
 
 
 
Lesson of the Week
 
Tracking insider buying is a way to find situations that warrant attention.
Read More
 
 
 

 

Latest Videos
 
 
This week on RedChip TV: Two Small-Caps Targeting Massive Market Opportunities
 
This week’s episode of the RedChip Money Report features interviews with senior executives from Defi Technologies (OTCQB: RDNAF) and ComSovereign Holding (NASDAQ: COMS).
 
Watch Now
 
 
 
 
EVmo: Leading Provider of Rental Vehicles for the Gig Economy
 
EVmo (OTC: YAYO) bridges the gap between rideshare drivers in need of a suitable vehicle and rideshare companies that depend on attracting and keeping drivers. EVmo uniquely supports drivers in both the higher and lower economic categories with innovative policies and programs. EVmo is a leading provider of rental vehicles to drivers in the ever-expanding gig economy. EVmo maintains its own fleet of vehicles, which are rented to rideshare/delivery drivers, while providing insurance coverage and insurance cards in the drivers’ names to ensure drivers meet the stringent requirements of rideshare and logistics companies.
 
Watch Now
 
 
 
 
Killi: Transforming the $247B Market for Personal Data
 
Founded in 2018 and with offices in New York & Toronto, Killi (TSXV: MYID; OTCQB: MYIDD) is a company driven by the evolution of data and privacy. Killi aims to democratize data for consumers by providing them with an ecosystem where they can view, edit, opt-out, and be compensated for the use of their data. Today there is no destination for consumers to participate in the use of their data. Killi aspires to be the destination that consumers visit to reclaim control of their online data. Available on the web and in both the iOS and Google Play stores, Killi allows consumers to opt-in to share specific pieces of data with brands, agencies, and companies in exchange for compensation from the use of their personal data. All Killi data is first-party, global, and privacy complaint (CCPA/GDPR).
 
Watch Now
 
 
 
 
Elixinol: Industry Pioneer Set for Rapid Growth
 
Elixinol (OTC: ELLXF) is an original pioneer in the CBD industry — focused on the science, research and development of world-class cannabinoid products that provide real results for real people. A global company with a proven track record of growing and extracting premium-quality hemp, Elixinol's products are sold online at Elixinol.com, at over 2,600 natural, specialty and conventional grocery stores and pharmacies across the U.S., and around the world. Elixinol distributes CBD products in North and South America, throughout Europe, Asia and the Pacific Region under its own label, as well as bulk CBD and wholesale CBD.
 
Watch Now
 
 
 
 
BTCS: Pioneer in Blockchain Space
 
BTCS Inc. (OTCQB: BTCS) is an early entrant in the digital asset market and one of the first U.S. publicly traded companies focused on digital assets and blockchain technologies. BTCS resumed its transaction verification services business segment in the first quarter of 2021 with a focus on validating transactions and operating nodes on proof-of-stake blockchains.
 
Watch Now
 
 
 
 
DeFi Technologies: Transforming the Global Financial System
 
Led by co-founders Wouter Witvoet and Olivier Roussy Newton, who collectively raised $1.4B in their prior two deals, DeFi Technologies (OTC: RDNAF) is well positioned to become a key player in the rapidly growing decentralized finance industry. The market size for the industry is measured in the trillions and spans multiple sectors, including insurance, derivatives, credit and lending, asset management, and exchanges.
 
Watch Now
 
 
 
 
Learn Why Robert Blair, The Visionary Architect Behind Lulu Lemon (LULU) Joined RYU Apparel
 
RYU Apparel (OTCQB: RYPPF), or Respect Your Universe, is an award winning urban athletic apparel brand that engages in the development, marketing, and distribution of apparel, bags and accessories. Our products are engineered for the fitness, training and performance of the multi-discipline athlete. Our products are designed, developed and tested at our corporate headquarters in Vancouver, BC, Canada. Production takes place in factories located in North America and Asia.
 
Watch Now
 
 
 
 
Lantern Pharma: Transforming Cancer Drug Development with A.I.
 
Lantern Pharma (Nasdaq: LTNR) is a clinical stage biotechnology company leveraging its RADR® artificial intelligence (“A.I.”) platform to transform the pace, risk and cost of oncology drug development. RADR® A.I. quickly and efficiently develops precise genetic signatures of disease that underpin the identification of patients for whom its portfolio of oncology drug candidates is likely to have the greatest therapeutic effect. Lantern is currently developing three drug candidates in solid tumors.
 
Watch Now
 
 
 
 
Kiromic BioPharma: AI-Driven Immuno-Oncology Therapy Development
 
Kiromic BioPharma (Nasdaq: KRBP) is revolutionizing next-generation allogenic CAR therapies for solid tumors. The Company’s proprietary target discovery engine, Diamond uses AI and a proprietary neural network to identify development targets, dramatically compressing man years and billions of drug development dollars required to develop new live drugs.
 
Watch Now
 
 
 
 
Aridis Pharmaceuticals: Developing Novel Anti-Infective Therapies
 
Aridis Pharmaceuticals (Nasdaq: ARDS) discovers and develops anti-infectives to be used as add-on treatments to standard-of-care antibiotics. The Company is utilizing its proprietary ʎPEXTM and MabIgX® technology platforms to rapidly identify rare, potent antibody-producing B-cells from patients who have successfully overcome an infection, and to rapidly manufacture monoclonal antibody (mAbs) for therapeutic treatment of critical infections.
 
Watch Now
 
 
`
 
 
COMSovereign Corporate Overview with CEO & CTO
 
COMSovereign Holding (Nasdaq: COMS) Chairman & CEO Dan Hodges, along with Chief Technology Officer Dr. Dustin McIntire, share insight into the Company’s portfolio of communications technology companies and how they are expected to drive rapid growth in 2021 and beyond. Through strategic acquisitions and organic research and development efforts, COMSovereign has become a U.S.-based communications provider able to provide 4G LTE Advanced and 5G-NR telecom solutions to network operators and enterprises.
 
Watch Now
 
 
 
 
Hoth Therapeutics: Developing a New Generation of Therapies for Unmet Medical Needs
 
Hoth Therapeutics (Nasdaq: HOTH) is a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical needs. Hoth's clinical pipeline is concentrated on drug candidates that improve the quality of life for patients suffering from indications including atopic dermatitis, skin toxicities associated with cancer therapy, chronic wounds, psoriasis, asthma, acne, mast-cell derived cancers & anaphylaxis and pneumonia.
 
Watch Now
 
 
 
 
Can-Fite BioPharma: Advanced Clinical Stage Drug Development
 
Can-Fite BioPharma (NYSE American: CANF) has an advanced pipeline of proprietary compounds in phase 2 and 3 clinical development stage, which address autoimmune-inflammatory and cancer diseases. The company’s platform technology utilizes the Gi protein associated A3 adenosine receptor (A3AR) as a therapeutic target. A3AR is highly expressed in inflammatory and cancer cells where low expression is found in normal cells, suggesting that the receptor could be a unique target for pharmacological intervention.
 
Watch Now
 
 
 
 
Esports Entertainment Group CEO Discusses Plans for Rapid Growth
 
Interview with CEO of Esports Entertainment Group Inc. (NASDAQ: GMBL), a full stack esports and online gambling company fueled by the growth of video-gaming and the ascendance of esports with new generations. Its mission is to help connect the world at large with the future of sports entertainment in unique and enriching ways that bring fans and gamers together. Esports Entertainment Group and its affiliates are well-poised to help fans and players to stay connected and involved with their favorite esports.
 
Watch Now
 
 
 
 
Alset EHome International: Diversified Operations Accelerating Sustainable Healthy Living
 
Alset EHome International (Nasdaq: AEI) is a diversified holding company principally engaged through its subsidiaries in property development, digital transformation technology and biohealth activities with operations in the United States, Singapore, Hong Kong, Australia and South Korea.
 
Watch Now
 
 
 
 
CBD of Denver: Corporate Overview
 
CBD of Denver (OTC: CBDD) is a full-line CBD and hemp oil company, producing and distributing cannabis and CBD products in Switzerland, Europe, and the US. CBDD is focused on using equity to acquire profitable Swiss assets at attractive valuations to create value for its shareholders and is driven by a passion to improve lives and strengthen communities by unleashing the full potential of cannabis.
 
Watch Now
 
 
 
 
Nano Dimension: CEO Discusses Acquisition Strategy
 
Nano Dimension (NASDAQ: NNDM) is a provider of intelligent machines for the fabrication of Additively Manufactured Electronics (AME). High fidelity active electronic and electromechanical subassemblies are integral enablers of autonomous intelligent drones, cars, satellites, smartphones, and in vivo medical devices.
 
Watch Now
 
 
 
 
American Resources: Next-Generation Raw Materials Supplier for New Infrastructure
 
American Resources Corp. (Nasdaq: AREC) is a next-generation, environmentally and socially responsible supplier of high-quality raw materials to the new infrastructure market. The Company is focused on the extraction and processing of metallurgical carbon, an essential ingredient used in steelmaking, critical rare earth minerals for the electrification market, and reprocessed metal to be recycled.
 
Watch Now
 
 
 
 
Draganfly: Drone Technology Solving Real World Challenges
 
Draganfly (OTCQB: DFLYF) has been a leader in the professional drone industry for more than 20 years, supporting clients with enterprise drone solutions, contract engineering services, custom software, professional unmanned aerial vehicle (UAV) services, and more. From public safety to pop culture, Draganfly has shaped not just the UAV industry, but the way people around the world work and live.
 
Watch Now
 
 
 
 
Genetic Technologies: Innovative Tests to Determine Disease Risk
 
Genetic Technologies (Nasdaq: GENE) is a diversified molecular diagnostics company developing tools for the prediction and assessment of cancer risk to help physicians proactively manage patient health. The Company’s lead products, ‘GeneType for Breast Cancer’ and ‘GeneType for Colorectal Cancer’, are clinically validated risk assessment tests that are first in their class. The Company’s development pipeline includes new tests for COVID-19, Type 2 diabetes, cardiovascular disease, prostate cancer, and melanoma.
 
Watch Now
 
 
 
 
CBD of Denver: High-Growth Business Targeting US and Europe
 
CBD of Denver (OTC: CBDD) is a full-line CBD and hemp oil company, producing and distributing cannabis and CBD products in Switzerland, Europe, and the US. CBDD is focused on using equity to acquire profitable Swiss assets at attractive valuations to create value for its shareholders and is driven by a passion to improve lives and strengthen communities by unleashing the full potential of cannabis.
 
Watch Now
 
 
 
 
Amesite: Award-Winning AI-Driven Learning for Institution
 
Amesite (Nasdaq: AMST) is a high-tech artificial intelligence (AI) software company offering a cloud-based platform and content creation services for K-12, college, university and business education and upskilling. Amesite-offered courses and programs are branded to its customers.
 
Watch Now
 
 
 
 
BioVie: Developing Potential Game-Changing Treatments for Liver Disease
 
BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing innovative drug therapies for liver disease. The Company’s drug candidate, BIV201 (continuous infusion terlipressin), has an Orphan Drug designation for the treatment of refractory ascites, FDA Fast Track status, and US patent pending. BIV201 also has an Orphan Drug designation for the treatment of hepatorenal syndrome (HRS).
 
Watch Now
 
 
 
 
DSG Global: Positioned for Rapid Growth in Electric Vehicle Market
 
DSG Global (OTCQB: DSGT) is an emerging global technology company with an array of interconnecting businesses in some of the fastest growing market sectors.
 
Watch Now
 
 
 
 
Small-Cap NASDAQ Solar Company Positioned for Rapid Growth
 
Delivering competitive, clean energy solutions to customers for more than 15 years, SPI Energy (NASDAQ: SPI) is an established renewable energy player with global operations in key markets in Asia, Australia, North America, and Europe.
 
Watch Now
 
 
 
 
CEO Interview with OLB Group: High-Growth Fintech Company on the Move
 
The OLB Group (NASDAQ: OLB) is led by a team of seasoned industry executives with extensive experience in payments, ecommerce, and mobile commerce. Trading at 3x sales, upside could be significant in an industry where peer comps trade as high as 39x sales. Aegis Capital gave OLB a buy rating and $9 price target in its latest report on the Company. Learn more at OLBGinfo.com.
 
Watch Now
 
 
 
 
Tiziana Life Sciences: CEO Discusses Positive Data from COVID-19 Trial
 
Tiziana Life Sciences (Nasdaq: TLSA) is a clinical stage biotechnology company focused on the discovery and development of novel molecules to treat human disease in oncology and immunology. Tiziana’s two lead drug candidates, Foralumab and Milciclib, uniquely target the root cause of diseases with large unmet needs in multibillion-dollar markets.
 
Watch Now
 
 
 
 
Greenwich LifeSciences: Phase 3 Targeting Recurrent Breast Cancer
 
Greenwich LifeSciences (NASDAQ: GLSI) is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery.
 
Watch Now
 
 
 
 
Bragg Gaming: Technology Infrastructure for the Global Gaming Industry
 
Bragg Gaming Group Inc. (OTC: BRGGF) is a next generation gaming group with cutting-edge technology, leading brands and world-class management expertise, developing into a global gaming force. Formed by a team of gaming industry experts, Bragg's main portfolio is ORYX Gaming, an innovative B2B gaming technology platform and casino content aggregator.
 
Watch Now
 
 
 
 
Order Small Stocks, Big Money Today!
 
Dave Gentry is the author of Small Stocks, Big Money: Interviews With Microcap Superstars. Published by Wiley, this first-hand perspective on the fast world of microcap investing is now available for purchase.
 
 
MidSouth Week in Review
 
Consumer confidence surged in March to a one-year high of 109.7 vs. 90.4 in February.
Read More
 
 
 
 
About RedChip
 
RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on small-cap and mid-cap companies. Since 1992, RedChip has delivered concrete, measurable results for its clients through the most comprehensive service platform in the industry for small-cap and mid-cap companies. These services include a worldwide distribution network for its stock research written by analysts holding the CFA designation; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated over 2.3 million unique investor views; quarterly global online institutional and retail investor conferences that reach over 10,000 investors annually; "The RedChip Money Report" television show which airs in 100 million homes across the U.S. on The Family Channel; a weekly newsletter delivered to 60,000 investors; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more.
 
RedChip Disclosure
 
RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.
RedChip Visibility is a division of RedChip Companies, Inc. and offers research services to paying clients. In the purview of Section 17(b) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention to the fact that the RedChip Companies Inc. is an investor relations firm hired by certain Companies to increase investor awareness to the small-cap equity community.
Stock market investing is inherently risky. RedChip Companies is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print.
We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov and view RedChip’s Disclosures.
 
 
     
 
 
Copyright © 2020 RedChip Companies, Inc. All Rights Reserved.
You are receiving this message because this email address has signed up to receive News Alerts.